Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women

Fertility and Sterility

Volumn 69, Issue 2, 1998, Pages 267-273

  Chen, Fang Ping ^a,b   Lee, Ning ^a,b   Wang, Chao Hung ^a,b   Cherng, Wen Jin ^a,b   Soong, Yung Kui ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Department of Obstetrics and Gynecology ^*

Author keywords

Combined hormone replacement therapy; Endothelin l; Hemostatic parameters; Left ventricular function; Lipoprotein profile; Platelet aggregation

Indexed keywords

ESTRADIOL VALERATE; ESTRADIOL VALERATE PLUS MEDROXYPROGESTERONE ACETATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; FEMALE; HEART LEFT VENTRICLE FUNCTION; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; INCIDENCE; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; TAIWAN; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME;

BLOOD COAGULATION FACTORS; CARDIOVASCULAR DISEASES; ELECTROCARDIOGRAPHY; ENDOTHELIN-1; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEMOSTASIS; HUMANS; LIPOPROTEINS; LONGITUDINAL STUDIES; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; PLATELET AGGREGATION; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0031951183     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)00487-1     Document Type: Article

References (25)

1. Stampfer MJ, Coldita GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
2. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325:1196-204
3. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, et al. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993;328:1069-75.
4. Sahn DJ, De Maria A, Kissol J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurement. Circulation 1978;58:1072-83.
5. Bush TL, Barrett-Connor E, Cowan LD, Cowan LD, Criqui MH, Wallace RB, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-9.
6. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208.
7. Tikkanen MJ, Nikkilä EA, Vartiainen E. Natural oestrogen as an effective treatment of type II hyperlipoproteinemia in postmenopausal women. Lancet 1978;ii:490-2.
8. Bush TL, Miller VT. Effects of pharmacologic agents used during menopause: impact on lipids and lipoproteins. In: Mishell DR, editor. Menopause: Physiology and pharmacology. Chicago: Year Book Medical Publishers; 1987;187-208.
9. Scarabin PY, Plu-Bureau G, Bara L, Bonithon-Kopp C, Guize L, Samama MM. Haemostatic variables and menopausal status: influence of hormone replacement therapy. Thromb Haemostas 1993;70:584-7.
10. Gebara OCE, Mittleman MA, Sutherland P, Lipinska I, Matheney T, Xu P, et al. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring study. Circulation 1995;91:1952-8.
11. Shahar E, Folsom AR, Salomaa VV, Stinson VL, McGovern PG, Shimakawa T, et al. Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 1996;93:1970-5.
12. Gilabert J, Estelles A, Cano A, Espana E, Barrachina R, Grancha S, et al. The effect of estrogen replacement therapy with or without progestogen on the fibrinolytic system and coagulation inhibitors in postmenopausal status. Am J Obstet Gynecol 1995;173:1849-54.
13. Devor M, Barrett-Connor E, Renvall M, Feigal D Jr, Ramsdell J. Estrogen replacement therapy and the risk of venous thrombosis. Am J Med 1992;92:275-82.
14. Lowe GDO, Greer IA, Cooke TG. Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group. Br Med J 1992;305:567-74.
15. Boschetti C, Cortellaro M, Nencioni T, Bertolli V, Della-Volpe A, Zanussi C. Short- and long-term effects of hormone replacement therapy (transdermal estradiol vs oral conjugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in postmenopausal women. Thromb Res 1991;62:1-8.
16. Melissari E, Kakkar VV. The effects of oestrogen administration on the plasma free protein S and C4b-binding protein. Thromb Res 1988;49:489-95.
17. Bar J, Tepper R, Fuchs J, Yoseph P, Goldberger S, Ovadia J. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women. Obstet Gynecol 1993;81:261-4.
18. Miller ME, Dores GM, Thorpe SL, Akerley WL. Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions. Thromb Res 1994;74:577-94.
19. Mendelsohn ME, Karas RH. Estrogen and blood vessel wall. Curr Opin Cardiol 1994;9:619-26.
20. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Endothelin in myocardial infarction. Nature 1990;344:114.
21. Ylikorkala O, Orpana A, Puolakka J, Pyörälä T, Viinikka L. Postmenopausal hormone replacement decrease plasma levels of endothelin-1. J Clin Endocrin Metab 1995;80:3384-7.
22. Kangro T, Henriksen E, Jonason T, Leppert J, Nilsson H, Sörensen S, et al. Effect of menopause on left ventricular filling in 50-year-old women. Am J Cardiol 1995;76:1093-6.
23. Sheuer J, Malthora A, Schaible TF, Capasso J. Effects of gonadectomy and hormonal replacement on rat hearts. Circ Res 1987;61:12-6.
24. Voutilainen S, Hippeläinen M, Hulkko S, Karppinen K, Ventilä M, Kupari M. Left ventricular diastolic function by Doppler echocardiography relation to hormonal replacement therapy in healthy postmenopausal women. Am J Cardiol 1993;71:614-7.
25. Pines A, Fisman EZ, Levo Y, Averbuch M, Lidor A, Drory Y, et al. The effects of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow. Am J Obstet Gynecol 1991;164:806-12.